Jeffrey Jones
Directeur Technique/Scientifique/R&D chez CULLINAN THERAPEUTICS, INC.
Fortune : 2 M $ au 30/04/2024
Profil
Jeffrey Jones is currently the Chief Medical Officer at Cullinan Oncology, Inc. He previously worked as the Vice President-Global Drug Development & Lymphoma at Bristol Myers Squibb Co. from 2017 to 2022.
Prior to that, he was an Associate Professor at The Ohio State University College of Medicine and the Chief Medical Officer at Cullinan Oncology LLC.
Dr. Jones holds an MBA from Fisher College of Business, a doctorate from the University of Michigan Medical School, and a graduate degree from The University of Texas Health Science Center at Houston.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 22/02/2024 | 118 691 ( 0,28% ) | 2 M $ | 30/04/2024 |
Postes actifs de Jeffrey Jones
| Sociétés | Poste | Début |
|---|---|---|
| CULLINAN THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 28/02/2022 |
Anciens postes connus de Jeffrey Jones
| Sociétés | Poste | Fin |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Directeur Technique/Scientifique/R&D | 01/04/2020 |
| The Ohio State University College of Medicine | Corporate Officer/Principal | - |
Cullinan Oncology LLC
 Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Directeur Technique/Scientifique/R&D | - |
Formation de Jeffrey Jones
| University of Michigan Medical School | Doctorate Degree |
| Fisher College of Business | Masters Business Admin |
| The University of Texas Health Science Center at Houston | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CULLINAN THERAPEUTICS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Entreprise privées | 1 |
|---|---|
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Finance |
